• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDiabetes

Diabetes

Ozempic
HealthNovo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By Nick LichtenbergAugust 18, 2025
OpenAI CEO Sam Altman testifies during a Senate Commerce, Science and Transportation Committee hearing on May 8, 2025. (Photo: Tom Williams/CQ-Roll Call/Getty Images)
NewslettersBehold, an AI model from OpenAI that’s…open
By Andrew NuscaAugust 6, 2025
Barbie
RetailMattel just introduced its first Barbie doll with Type 1 diabetes
By The Associated PressJuly 9, 2025
LifestyleWhy drinking sugar may be worse than eating it
By Beth GreenfieldJune 10, 2025
LifestyleThis plant compound could lower your risk of heart disease and diabetes, according to new research
By Ani FreedmanJune 4, 2025
ConferencesHalf the world population could be diabetic or insulin resistant by 2050
By Ian MountMay 26, 2025
HealthJust how much ultra-processed food are we eating? Markers in blood and urine may hold a clue
By Jonel Aleccia and The Associated PressMay 20, 2025
LifestyleThe secret trick to turning carbohydrates like white rice and bread into superfoods
By Ani FreedmanMay 12, 2025
LifestyleMen are more likely to get sick and less likely to seek care for 3 common diseases, study finds
By Ani FreedmanMay 7, 2025
Chrissy Teigen sitting on a couch with her son Miles
HealthWhy Chrissy Teigen is speaking out about her 6-year-old’s Type 1 diabetes diagnosis
By Beth GreenfieldApril 28, 2025
LifeEating your meals at these exact times could boost your energy levels and prevent chronic disease
By Ani FreedmanApril 10, 2025
Pregnant woman getting a sonogram
FamilyResearchers uncover a link to autism—and it isn’t vaccines
By Beth GreenfieldApril 8, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
A woman injects herself with medication.
HealthOzempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
A person stands on a scale.
HealthHims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...9
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.